SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Applied Digital Corporation

Applied Digital is drawing significant attention as investors position themselves ahead of upcoming earnings and potential catalysts, including speculation surrounding a major hyperscaler lease deal. The community is actively debating the stock's high short interest and the potential for a squeeze, while balancing optimism for long-term AI infrastructure growth against broader macro-political volatility.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is experiencing a surge in investor interest fueled by a string of recent follow-on orders for its silicon photonics wafer-level test and burn-in systems from major hyperscale customers. The community is heavily focused on the companys potential as a critical bottleneck provider for AI infrastructure, with intense debate centering on whether the current valuation reflects early-cycle demand inflection or unsustainable speculative hype.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as investors debate ongoing market volatility, with the community split between frustration over stagnant price action and persistent anticipation of a potential squeeze or strategic acquisition. Discussions are dominated by allegations of dark pool manipulation and supply distortion, while bulls continue to push the long-term thesis despite broader market gains leaving the stock behind.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is trending as investors scrutinize CEO Greg Abel's leadership following weak quarterly earnings and a ballooning cash pile, with the community sharply divided between those viewing the stock as a 'dead money' legacy trap and those betting on its potential as a defensive fortress amidst market volatility. Discussion is heavily focused on the company's lack of aggressive capital deployment, the underperformance relative to major indexes, and the intense anticipation surrounding its upcoming 13F filing and potential buyback strategy.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is seeing renewed bullish sentiment as investors react to a newly announced two-week ceasefire in the Middle East and the anticipated launch of the Morgan Stanley spot ETF. The community is actively debating the sustainability of this price action, with many discussing whether the current trend represents a short squeeze or a broader shift in institutional demand.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is facing significant selling pressure as investors react to concerns over share dilution and a broader pullback in AI infrastructure stocks. While the community remains divided, many are focused on the company's 4.5 GW power pipeline and upcoming capacity energizations as critical catalysts for a potential rebound.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is currently navigating a period of heightened geopolitical sensitivity as traders weigh the impact of potential regional instability on major digital assets. Community sentiment is deeply divided between cautious observers monitoring global macro events and bullish market participants who are actively accumulating positions in anticipation of a definitive structural breakout.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is experiencing extreme volatility as market participants react to a two-week ceasefire agreement between the U.S. and Iran, which aims to reopen the critical Strait of Hormuz. Community sentiment is deeply divided, with traders debating whether this development marks a structural end to the war premium or a temporary pause that will trigger a sharp reversal as negotiators face incompatible demands.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending as traders closely track its resilience in a volatile market following analyst upgrades and a strategic price increase across subscription tiers. Community sentiment remains split between bullish investors betting on long-term growth and ad revenue expansion, and those concerned about potential subscriber churn from pricing hikes.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is trending as traders analyze the impact of recent protocol vulnerabilities alongside broader crypto market volatility and shifting institutional interest. The community remains highly active, balancing debates over network reliability with speculative excitement around emerging meme coins and the potential for a rebound following key geopolitical developments.

statis crypto Watchlist

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$OTLK Need an honest opinion...I&#39;ve read...&quot;FDA reverses their decision during these meetings 16% of the time&quot; 
Is a very low percentage I think the management know too. 
So if you know that the percentage of success rate is so  low...what do you have in your hands that make you think you can do it? 
I don&#39;t think the management will show up with anything.

George

Johannes

Jose Antonio Diaz

KiwiGOD

StockTwits Web

Outlook Therapeutics Inc

 Need an honest opinion...I've read..."FDA reverses their decision during these meetings 16% of the time" 
Is a very low percentage I think the management know too. 
So if you know that the percentage of success rate is so  low...what do you have in your hands that make you think you can do it? 
I don't think the management will show up with anything.

@Enea1977 If there’s one thing I’ve learned, it’s that talking about percentages in these kinds of decisions is worthless. Remember what we went through in December: “Don’t worry, it’s a Class 1 and it has an approval rate above 90%.”

If they want to approve it, they will, and if not, they won’t, but it will be driven by uncontrollable factors given the level of corruption at the FDA. It’s like flipping a coin.

At the very least, I hope that in the worst-case scenario they provide a clear pathway on what needs to be done to get approval, avoiding a new trial.

Bayesed

Benjamin Couture

Financial Freedom Seeker

Sue Hwang

6 Year OTLK Vet

Pastime

Elyon Industries

Ambino Umberto

Doublechecker

StockTwits For Android 

 If there’s one thing I’ve learned, it’s that talking about percentages in these kinds of decisions is worthless. Remember what we went through in December: “Don’t worry, it’s a Class 1 and it has an approval rate above 90%.”

If they want to approve it, they will, and if not, they won’t, but it will be driven by uncontrollable factors given the level of corruption at the FDA. It’s like flipping a coin.

At the very least, I hope that in the worst-case scenario they provide a clear pathway on what needs to be done to get approval, avoiding a new trial.

Marcos HC

@Enea1977 Here&#39;s how I see it:

1-Admit the math is against OTLK here.
2-Realise that unlike a lot of companies in that 84% failure rate, LYTENAVA is actually approved in other markets where safety and efficacy are being proved daily.
3-New data could&#39;ve been collected in the past 4 months from Europe which weren&#39;t included in the last BLA but will be presented in the FDRR.
4-Even a rejection could make a path forward clearer for the company, as the reasons for rejection (or better yet, the sufficient reasons needed for approval) become straightforward
5-Very little room for a downtrend, you&#39;ll need an RS, a rejection and a dilution to go -50% from where the share price is at. The room is much bigger for an uptrend following an FDRR approval.

Racsoracso

Christian

Patrick Laurin

 Here's how I see it:

1-Admit the math is against OTLK here.
2-Realise that unlike a lot of companies in that 84% failure rate, LYTENAVA is actually approved in other markets where safety and efficacy are being proved daily.
3-New data could've been collected in the past 4 months from Europe which weren't included in the last BLA but will be presented in the FDRR.
4-Even a rejection could make a path forward clearer for the company, as the reasons for rejection (or better yet, the sufficient reasons needed for approval) become straightforward
5-Very little room for a downtrend, you'll need an RS, a rejection and a dilution to go -50% from where the share price is at. The room is much bigger for an uptrend following an FDRR approval.

@capitan101982 yes I remember in december...thanks for your opinion.

 yes I remember in december...thanks for your opinion.

@Enea1977 it’s not necessarily an approved/not approved scenario. It’s a meeting to discuss and obtain a clear understanding of what the FDA is actually wanting so they can give it to them.They can approve right there, but more than likely it’s going to be “resubmit with this or that” and we’re good

StockTwits for iOS

 it’s not necessarily an approved/not approved scenario. It’s a meeting to discuss and obtain a clear understanding of what the FDA is actually wanting so they can give it to them.They can approve right there, but more than likely it’s going to be “resubmit with this or that” and we’re good

@Enea1977 The FDRR is a legitimate formal mechanism, but the raw statistics are sobering. Of 140 unique appeals accepted and reviewed by CDER from 2003 to 2014, only 23 (16%) were granted, while 117 (84%) were denied. However, that headline number is misleading. In the experience of regulatory attorneys who’ve worked these cases, “Denial” often conceals important “Wins” in the sense of establishing a more favorable path to approval than originally presented — such as getting the FDA to accept a resubmission without a new Phase 3 trial, or accepting a different analytical method that yields approval. By one firm’s count over a three-year period, 78% of their FDRR cases resulted in meaningful wins, even though FDA’s official tally showed only 25% granted.

Joe Dirt

 The FDRR is a legitimate formal mechanism, but the raw statistics are sobering. Of 140 unique appeals accepted and reviewed by CDER from 2003 to 2014, only 23 (16%) were granted, while 117 (84%) were denied. However, that headline number is misleading. In the experience of regulatory attorneys who’ve worked these cases, “Denial” often conceals important “Wins” in the sense of establishing a more favorable path to approval than originally presented — such as getting the FDA to accept a resubmission without a new Phase 3 trial, or accepting a different analytical method that yields approval. By one firm’s count over a three-year period, 78% of their FDRR cases resulted in meaningful wins, even though FDA’s official tally showed only 25% granted.